Patents by Inventor Kyoichi Watanabe

Kyoichi Watanabe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4666892
    Abstract: The invention relates to 5-substituted-1-(2'-deoxy-2'-substituted-beta-D-Arabinofuranoysyl) pyrimidine compounds and their use in a method for the treatment of hepatitis B viruses.
    Type: Grant
    Filed: February 10, 1986
    Date of Patent: May 19, 1987
    Assignee: Sloan-Kettering Memorial Cancer Center
    Inventors: Jack J. Fox, Kyoichi A. Watanabe, Carlos Lopez, Christian G. Trepo
  • Patent number: 4594339
    Abstract: Veterinarian composition for the treatment of herpes virus in animals comprising a pyrimidine nucleoside, or veterinarianically acceptable acid addition salte thereof, of the formula ##STR1## wherein A is OR.sup.3, SR.sup.3, NR.sup.3 R.sup.4 or NHacyl wherein R.sup.3 and R.sup.4 are the same or different and are hydrogen, lower alkyl of 1 to 7 carbon atoms, aralkyl, or aryl;NHacyl is alkanoyl or aroyl amide;B is oxygen or sulfur;X is halogen, alkylsulfonyl or arylsulfonyl;Y is halogen, amino, monoalkyl- or monoaralkylamino, dialkylamino, aminomethyl, hydroxymethyl, lower alkyl, aryl, aralkyl, vinyl and substituted vinyl or ethynyl and substituted ethynyl;Z is methyne or nitrogen;R.sup.1 and R.sup.2 are the same or different and are hydrogen acyl or aroyl,in a veterinarianically acceptable carrier.
    Type: Grant
    Filed: June 18, 1984
    Date of Patent: June 10, 1986
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Carlos Lopez, Kyoichi A. Watanabe, Uri Reichman, Jack J. Fox
  • Patent number: 4211773
    Abstract: Pyrimidine nucleosides exhibiting anti-viral and anti-tumor effects have the formula ##STR1## wherein A is OR.sup.3, SR.sup.3, NR.sup.3 R.sup.4 or NHacyl wherein R.sup.3 and R.sup.4 are the same or different and are hydrogen, lower alkyl of 1 to 7 carbon atoms, aralkyl, or aryl;NHacyl is alkanoyl or aroyl amide;B is oxygen or sulfur;X is halogen, alkylsulfonyl or arylsulfonyl;Y is halogen, amino, monoalkyl- or monoaralkylamino, dialkylamino, aminomethyl, hydroxymethyl, lower alkyl, aryl, aralkyl, vinyl and substituted vinyl or ethynyl and substituted ethynyl;Z is methyne or nitrogen;R.sup.1 and R.sup.2 are the same or different and are hydrogen acyl or aroyl.
    Type: Grant
    Filed: October 2, 1978
    Date of Patent: July 8, 1980
    Assignee: Sloan Kettering Institute for Cancer Research
    Inventors: Carlos Lopez, Kyoichi A. Watanabe, Uri Reichman, Jack J. Fox
  • Patent number: 4171429
    Abstract: There is provided a novel process for pyrimidine to pyrimidine transformations by the displacement of the 1,2,3-portion of a pyrimidine by a 1,3-ambident nucleophile. The novel process requires that the 1 and 3 nitrogens of the pyrimidine moiety be substituted. The novel process makes available, inter alia, novel uracils, simple methods of radioisotopically labeling pyrimidine nuclei, a simple and inexpensive method of preparing the important antiviral and antileukemic material pseudoisocytidine and its new active analog 2'-deoxypseudoisocytidine.
    Type: Grant
    Filed: March 29, 1977
    Date of Patent: October 16, 1979
    Assignee: Research Corporation
    Inventors: Kyoichi A. Watanabe, Kosaku Hirota, Chung K. Chu, Uri Reichman, Jack J. Fox
  • Patent number: 4074042
    Abstract: Pseudo-isocytidine is disclosed as well as methods and intermediates useful in its preparation. The novel compound pseudo-isocytidine, preferably the beta-anomer thereof, is an active cytostatic and anti-leukemic agent.
    Type: Grant
    Filed: August 7, 1975
    Date of Patent: February 14, 1978
    Assignee: Research Corporation
    Inventors: Kyoichi A. Watanabe, Chung K. Chu, Jack J. Fox